NASDAQ : NGNE

Neurogene Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 27.55 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 551.31M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports